PCI Synthesis Adds cGMP Advanced Polymer Development and Manufacturing Group

PCI Synthesis, Inc. has announced the formation of its cGMP Advanced Polymer Development and Manufacturing Group, which is currently developing and manufacturing more than a dozen advanced polymer-based projects.  As the largest independent cGMP contract manufacturing organization (CMO) in New England, the addition of an advanced polymer-based materials development and manufacturing capability significantly expands the company’s customer base and reach within this growing market.

The team currently includes several Ph.D.-level polymer chemists with broad expertise in the development, scale up, and eventual cGMP manufacturing of these important materials. The team is also supported by PCI Synthesis’s existing and well-respected Kilo Lab team. Products in development include a broad range of polymer-based materials, including:

  • Implantable medical devices including biodegradable implants.
  • Nano-polymer particle technology.
  • Combination API and polymer technologies.
  • Drug delivery technologies.
  • Therapeutics and excipients.
  • Medical-grade coatings.

The PCI Synthesis Advanced Polymer Manufacturing Group operates out of the company’s development lab in Devens, Mass., and collaborates with its cGMP facilities in Newburyport, Mass. 

  • <<
  • >>

Join the Discussion